1.
Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects
by Lill, Christina M
Journal of medical genetics, 2012-09, Vol.49 (9), p.558-562
2.
Genetic risk factors for cerebral small-vessel disease in hypertensive patients from a genetically isolated population
by Schuur, M
Journal of neurology, neurosurgery and psychiatry, 2011-01, Vol.82 (1), p.41-4
3.
Cognitive Impairment in Alzheimer’s Disease Is Modified by APOE Genotype
by van der Vlies, Annelies E
Dementia and geriatric cognitive disorders, 2007-07, Vol.24 (2), p.98-103
4.
Gene-centric Association Signals for Lipids and Apolipoproteins Identified via the HumanCVD BeadChip
by Talmud, Philippa J
American journal of human genetics, 2009-11-13, Vol.85 (5), p.628-642
5.
Apolipoprotein E in Alzheimer's disease: an update
by Yu, Jin-Tai
Annual review of neuroscience, 2014, Vol.37 (1), p.79-100
6.
Apolipoprotein E Sets the Stage: Response to Injury Triggers Neuropathology
by Mahley, Robert W
Neuron (Cambridge, Mass.), 2012-12-06, Vol.76 (5), p.871-885
7.
Whole-Exome Sequencing Identifies Rare and Low-Frequency Coding Variants Associated with LDL Cholesterol
by Schmidt, Ellen M
American journal of human genetics, 2014-02-06, Vol.94 (2), p.233-245
8.
The Role of Apolipoprotein E in Alzheimer's Disease
by Kim, Jungsu
Neuron (Cambridge, Mass.), 2009, Vol.63 (3), p.287-303
9.
Genetic associations in diabetic nephropathy: a meta-analysis
by Mooyaart, A. L
Diabetologia, 2010-12-03, Vol.54 (3), p.544-553
10.
MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1
by Schober, Aneas
Nature medicine, 2014-04, Vol.20 (4), p.368-+
11.
PET Imaging of Tau Deposition in the Aging Human Brain
by Schöll, Michael
Neuron (Cambridge, Mass.), 2016-03-02, Vol.89 (5), p.971-982
12.
Genetic predisposition, modifiable-risk-factor profile and long-term dementia risk in the general population
by Licher, Silvan
Nature medicine, 2019-09, Vol.25 (9), p.1364-1369
13.
American Medical Society for Sports Medicine position statement: concussion in sport
by Harmon, Kimberly G
British journal of sports medicine, 2013-01, Vol.47 (1), p.15-26
14.
GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease
by Cruchaga, Carlos
Neuron (Cambridge, Mass.), 2013-04-24, Vol.78 (2), p.256-268
15.
Estrogen use and early onset Alzheimer's disease: a population-based study
by Slooter, Arjen J C
Journal of neurology, neurosurgery and psychiatry, 1999-12, Vol.67 (6), p.779-297
16.
APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis
by Rannikmäe, Kristiina
Journal of neurology, neurosurgery and psychiatry, 2014-03, Vol.85 (3), p.300-305
17.
Genome-wide Association Analysis Reveals Putative Alzheimer's Disease Susceptibility Loci in Addition to APOE
by Bertram, Lars
American journal of human genetics, 2008-11-17, Vol.83 (5), p.623-632
18.
GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE−/− Mice
by Panjwani, Naim
Endocrinology (Philadelphia), 2013-01, Vol.154 (1), p.127-139
19.
Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis
by Wagschal, Alexandre
Nature medicine, 2015-11, Vol.21 (11), p.1290-1297
20.
Candidate genes for temporal lobe epilepsy: a replication study
by Salzmann, Annick
Neurological sciences, 2008-12-06, Vol.29 (6), p.397-403
